Nestl Health Science SA, a fully-owned subsidiary of Nestl SA, and Hutchison China MediTech have announced that all regulatory approvals required for the establishment of a 50/50 joint venture Nutrition Science Partners Limited have been received.
Hutchison China MediTech said that the purpose of the joint venture would be to research, develop, manufacture and market novel medicines and nutritional products derived from botanical plant origins.
The company added that Nutrition Science Partners would focus on gastrointestinal indications and could in the future expand into the metabolic disease and brain health areas.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Hutchison China MediTech's share price was up 3.85% to 526.50p at 11:13 on Friday.
MF
-
Why CEOs deserve a pay riseOpinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
-
Europe prepares to stand alone as Trump turns on UkraineSupport for old military alliances is wavering in the US under Donald Trump. Europe’s leaders are rushing to fill the void. Simon Wilson reports
